Up­dat­ed: Re­silience to cut most staff, sus­pend op­er­a­tions at Mass­a­chu­setts man­u­fac­tur­ing plant

Na­tion­al Re­silience, a biotech man­u­fac­tur­ing start­up fund­ed with more than $2 bil­lion since its launch in Ju­ly 2020, has sent no­tices to em­ploy­ees that it will cut jobs at a Mass­a­chu­setts man­u­fac­tur­ing site that it bought just two years ago, cit­ing re­duced de­mand.

Mul­ti­ple peo­ple whose LinkedIn pro­files said they had been em­ploy­ees at the plant post­ed over the week­end say­ing they were told the site will shut down. In a fol­low-up in­ter­view, CEO Rahul Singhvi told End­points News that Re­silience is keep­ing the fa­cil­i­ty in a “state of readi­ness” as it seeks new cus­tomer[s]. The com­pa­ny has put $150 mil­lion to $200 mil­lion in­to the site since ac­quir­ing it.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER